|
|
 |
|
Viewing report
|
|
|
|
The Genomics Outlook To 2005: Transforming Pharmaceutical And Diagnostic Markets
Business Insights, Jan 2002
Genomics is quietly transforming the pharmaceutical industry. Companies are moving from medicinal chemistry based drug discovery and development, to using information provided by genomics. Virtually all of the major pharmaceutical houses have either formed partnerships with genomics firms that began to emerge in the early 1990s or have created in-house genomics divisions. The Genomics Outlook to 2005: Transforming pharmaceutical and diagnostic markets examines new genomic approaches to drug discovery and development, focusing on how these technologies can be used most effectively and in a high-throughput capacity. Case studies analyzing applications of genomic technologies to specific disease-related research are provided, and future trends and developments are forecast.
Customers who bought this item also bought
Proteomics - Technologies, Markets and Companies
DNA Sequencing - Technologies, Markets and Companies
Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine
Biochips and Microarrays - Technologies, Markets and Companies
Cytogenetics - Technologies, Markets and Companies
Has Genomics Failed to Deliver?
Genetics Bundle
Enabling Innovation: Drug Development Through Biomarker Validation and Qualification
Animal Biotechnology - Technologies, Markets and Companies
Driving Drug and Diagnostic R&D: The Undeniable Influence of Biomarkers
|
|
|
|
